EQ today
$1.32-$0.10 (-7.04%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourSymmetric Triangle
1 hourSymmetric Triangle
15 minLeaning Bullish
5 minStrong Bearish
Daily trend turns up above $2.69
Key levels
Resistance$1.61
Resistance$1.48
Support$1.29
Support$1.16
Latest news & SEC filings
SEC FilingEquillium, Inc. filed a shelf registration for future offerings (Form S-3)
EarningsEquillium posts quarterly loss of $0.04 per share, topping $0.05 estimate
All EQ news →About Equillium
Equillium is a biotechnology company working on treatments for serious autoimmune and inflammatory conditions. Its main program, EQ504, is an early-stage aryl hydrocarbon receptor modulator aimed at ulcerative colitis and other digestive tract diseases, with possible expansion into lung inflammation. A second program, EQ302, is an orally delivered compound that blocks two specific cytokines and is being evaluated for celiac disease and related gut disorders. The company is based in the United States and uses outside contractors for manufacturing and clinical work.
Based on the company's 10-K filed Mar 25, 2026.
Nasdaq · Healthcare
Equillium, Inc. (EQ)
What Is the Price Target for EQ?
SEPT Low Target
$6.00
SEPT Mid Target
$6.00
SEPT High Target
$10.00
Analyst Consensus
$6.00
Is EQ a Buy or Sell Right Now?
Thesis
- •Revenue growing 13.9% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EQ.
Start Free Trial →Is EQ Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$4.83
25
Moat Score
NONE
2/9
Piotroski Score
4.3
Altman Z-Score
What Is Smart Money Doing with EQ?
Insider Signal
SELLING
0 buys / 10 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Zedelmayer Christine | officer | Buy | 14,584 | $11K | Jun 5, 2026 |
| Zedelmayer Christine | officer | Sale | 14,584 | $43K | Jun 5, 2026 |
| Connelly Stephen | officer | Sale | 30,975 | $91K | Jun 5, 2026 |
| Connelly Stephen | officer | Sale | 200,000 | $633K | Jun 4, 2026 |
| Tom Penny | officer | Buy | 65,000 | $51K | May 28, 2026 |
| Tom Penny | officer | Sale | 65,000 | $192K | May 28, 2026 |
| Zedelmayer Christine | officer | Buy | 7,292 | $5K | May 28, 2026 |
| Zedelmayer Christine | officer | Buy | 48,512 | $37K | May 28, 2026 |
| Zedelmayer Christine | officer | Sale | 55,604 | $150K | May 28, 2026 |
| Zedelmayer Christine | officer | Sale | 200 | $542.00 | May 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →EQ Growth Story
Revenue YoY
13.9%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-69.57%
FCF Growth YoY
-19.3%
Revenue Trend
STRONG
Dark Pool Trades for EQ
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for EQ, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:21:54 | $1.34 | 1,000 | $$1K | BUY |
| 23:19:52 | $1.35 | 1,000 | $$1K | BUY |
| 20:45:08 | $1.31 | 1,373 | $$2K | MIDPOINT |
| 19:50:13 | $1.31 | 2,000 | $$3K | BUY |
| 19:49:49 | $1.30 | 4,004 | $$5K | SELL |
5 dark pool trades shown · $$12K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Equillium, Inc. (EQ) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →EQ — frequently asked questions
What is EQ stock price today?
Equillium, Inc. (EQ) is at $1.32, down 7.04% (-$0.10) at the Nov 12, 2026 close.
Why is EQ stock moving today?
Latest EQ news — Nov 12, 2026: Equillium, Inc. filed a shelf registration for future offerings (Form S-3) · Nov 12, 2026: Equillium posts quarterly loss of $0.04 per share, topping $0.05 estimate
What is the EQ price target?
The average analyst price target for EQ is $6.00, ranging from $6 to $10, based on 5 analysts.
What do analysts rate EQ?
Analyst ratings for EQ: 5 Buy, 5 Hold, 0 Sell — consensus Hold.
Did EQ beat earnings?
EQ last reported on Aug 13, 2026: EPS -$0.04 vs -$0.05 expected — a beat of 25.9%.
Does EQ pay a dividend?
EQ does not currently pay a dividend.
What are EQ support and resistance levels?
Support: $1.29, $1.16, $0.84. Resistance: $1.48, $1.61, $1.75.
What are insiders doing with EQ?
Insider activity: SELLING, 0 buys and 10 sells in the last 90 days.
What is the latest news on EQ?
Nov 12, 2026: Equillium, Inc. filed a shelf registration for future offerings (Form S-3) · Nov 12, 2026: Equillium posts quarterly loss of $0.04 per share, topping $0.05 estimate